News

2019

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Seres Therapeutics Appoints Stephen Berenson to its Board of Directors

Seres Therapeutics 08.06.2019

Seres Therapeutics Issues Statement Regarding U.S. Food and Drug Administration Safety Alert Related to Use of Fecal Microbiota Transplantationse

Seres Therapeutics 06.19.2019

Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca

Seres Therapeutics 03.11.2019

Seres Therapeutics Announces Chief Executive Officer Transition

Seres Therapeutics 01.15.2019

Seres Therapeutics Announces Initiation of SER-287 Phase 2B ECO-RESET Clinical Study for Ulcerative Colitis

Seres Therapeutics 01.03.2019

Loading